PIK3CA and head and neck squamous cell carcinoma: Of note, we have also previously characterized the sensitivity of 28 HNSCC cell lines to PI3K inhibition and found both wildtype and PIK3CA-altered cell lines to be sensitive to PI3K inhibition [21].